Topics

VolitionRx Limited awarded an additional $1.4 million in non-dilutive funding

05:32 EDT 10 Jul 2019 | Proactive Investors

The grant will support a specific project to be conducted in collaboration with GIGA at the University of Liege, Belgium

Original Article: VolitionRx Limited awarded an additional $1.4 million in non-dilutive funding

NEXT ARTICLE

More From BioPortfolio on "VolitionRx Limited awarded an additional $1.4 million in non-dilutive funding"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...